Fair Value Measurements (Tables)

3 Months Ended

Mar. 28, 2025

Fair Value Disclosures [Abstract]

Schedule of financial assets and liabilities at carrying and fair value

A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):

	Quoted Prices in Active Market (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
March 28, 2025
Assets:
Cross-currency swap derivative contract	$	—	$	1.2	$	—	$	1.2
Investments in rabbi trust	$	15.6	$	8.0	$	—	$	23.6
Liabilities:
Deferred compensation plans	$	—	$	23.6	$	—	$	23.6
December 31, 2024:
Assets:
Cross-currency swap derivative contract	$	—	$	5.9	$	—	$	5.9
Investments in rabbi trust	$	16.0	$	8.2	$	—	$	24.2
Liabilities:
Deferred compensation plans	$	—	$	24.2	$	—	$	24.2

The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):

	March 28, 2025				December 31, 2024
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Assets:
Cross-currency swap derivative contract	$	1.2	$	1.2	$	5.9	$	5.9
Investments in rabbi trust	$	23.6	$	23.6	$	24.2	$	24.2
Liabilities:
Convertible senior notes due 2028	$	490.4	$	452.8	$	489.7	$	450.0
Convertible senior notes due 2025	$	116.2	$	116.5	$	116.0	$	125.4
Other debt	$	805.4	$	805.4	$	788.6	$	788.6